Literature DB >> 27864420

The Landscape of Viral Expression Reveals Clinically Relevant Viruses with Potential Capability of Promoting Malignancy in Lower-Grade Glioma.

Zheng Wang1,2,3, Yajing Hao4,5,6, Chuanbao Zhang1,2,3, Zhiliang Wang2,3, Xing Liu2,3, Guanzhang Li1,2,3, Lihua Sun1,2,3, Jingshan Liang1,2,3, Jianjun Luo4,5,6, Dabiao Zhou7, Runsheng Chen8,5, Tao Jiang9,2,3,10,11.   

Abstract

Purpose: RNA sequencing (RNA-seq) has recently proved to be effective for revealing novel virus-tumor associations. To get a thorough investigation of virus-glioma associations, we screened viruses in gliomas with RNA-seq data from the Chinese Glioma Genome Atlas project.Experimental Design: In total, 325 samples were enrolled into this study. Reads that failed to map to the human genome were aligned to viral genomes and screened for potential virus-derived transcripts. For quantification, VPKM was calculated according to mapped reads weighted by genome sizes and sequencing depth.
Results: We observed that viruses tended to concertedly express in a certain subgroup of patients. Survival analysis revealed that individuals who were infected with Simian virus 40 (SV40) or woolly monkey sarcoma virus (WMSV) had a significantly shorter overall survival than those uninfected. A multivariate Cox proportional hazards model, taking clinical and molecular factors into account, was applied to assess the prognostic value of SV40 and WMSV. Both SV40 and WMSV were independent prognostic factors for predicting patient's survival in lower-grade gliomas. Subsequent gene analysis demonstrated that SV40 was correlated with regulation of transcription, whereas WMSV was correlated with cell-cycle phase, which indicated frequent proliferation of tumor cells.Conclusions: RNA-seq was sufficient to identify virus infection in glioma samples. SV40 and WMSV were identified to be prognostic markers for patients with lower-grade gliomas and showed potential values for targeting therapy. Clin Cancer Res; 23(9); 2177-85. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27864420     DOI: 10.1158/1078-0432.CCR-16-1495

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  6 in total

1.  Serum IgG Antibodies from Pregnant Women Reacting to Mimotopes of Simian Virus 40 Large T Antigen, the Viral Oncoprotein.

Authors:  Elisa Mazzoni; Mariantonietta Di Stefano; Josè R Fiore; Federica Destro; Marco Manfrini; John Charles Rotondo; Maria V Casali; Fortunato Vesce; Pantaleo Greco; Gennaro Scutiero; Fernanda Martini; Mauro G Tognon
Journal:  Front Immunol       Date:  2017-04-10       Impact factor: 7.561

Review 2.  Association Between Simian Virus 40 and Human Tumors.

Authors:  John Charles Rotondo; Elisa Mazzoni; Ilaria Bononi; Mauro Tognon; Fernanda Martini
Journal:  Front Oncol       Date:  2019-07-25       Impact factor: 6.244

3.  Comparative profiling of immune genes improves the prognoses of lower grade gliomas.

Authors:  Zhiliang Wang; Wen Cheng; Zheng Zhao; Zheng Wang; Chuanbao Zhang; Guanzhang Li; Anhua Wu; Tao Jiang
Journal:  Cancer Biol Med       Date:  2021-10-09       Impact factor: 5.347

Review 4.  The role of human endogenous retroviruses in gliomas: from etiological perspectives and therapeutic implications.

Authors:  Ashish H Shah; Mark Gilbert; Michael E Ivan; Ricardo J Komotar; John Heiss; Avindra Nath
Journal:  Neuro Oncol       Date:  2021-10-01       Impact factor: 13.029

Review 5.  Genome Engineering Evolves Brain Tumor Modeling.

Authors:  Tomoyuki Koga; Clark C Chen; Frank B Furnari
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-06-15       Impact factor: 1.742

6.  Viral infection and glioma: a meta-analysis of prognosis.

Authors:  Zehao Cai; Shoubo Yang; Xiaoyan Li; Feng Chen; Wenbin Li
Journal:  BMC Cancer       Date:  2020-06-12       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.